Ofloxacin-Pos

Ofloxacin, the active ingredient in Ofloxacin-Pos, is a fluoroquinolone antibiotic presented as a sterile ophthalmic solution for ocular use. It treats bacterial infections of the eye, such as conjunctivitis, keratitis and blepharitis, in adult and pediatric patients as directed by a healthcare professional.

GNH USA supplies Ofloxacin-Pos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for cross‑border procurement. Customers benefit from reliable batch release, traceability and on‑time delivery across multiple regions.

Ofloxacin is a fluoroquinolone antibiotic used to treat bacterial infections of the ocular surface.

- Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of redness and discharge. - Keratitis: eradicates causative bacteria, promoting corneal healing and preventing scarring. - Blepharitis: eliminates bacterial colonisation of eyelid margins, improving inflammation and lid hygiene. - Post‑operative ocular infection: prevents bacterial proliferation after eye surgery.

Ocular administration of Ofloxacin-Pos may be associated with local adverse reactions.

Common Side Effects: - Eye irritation or burning sensation. - Stinging or foreign‑body feeling. - Transient blurred vision. - Conjunctival hyperemia.

Serious or Rare Side Effects: - Corneal ulceration or perforation. - Severe allergic reaction including eyelid edema. - Stevens‑Johnson syndrome or toxic epidermal necrolysis involving the eye. - Vision loss due to intraocular inflammation. - Persistent or worsening ocular pain.

Before prescribing Ofloxacin-Pos, clinicians should consider the following safety measures.

- Allergy assessment: avoid use in patients with known hypersensitivity to fluoroquinolones. - Contact lens wear: discontinue lenses during treatment to reduce risk of keratitis. - Systemic absorption: limit use to the eye; avoid excessive dosing. - Pregnancy and lactation: safety not established; use only if benefits outweigh risks. - Drug interactions: avoid concomitant use with ophthalmic corticosteroids unless directed. - Store at ambient temperature: keep in original container, protect from light and moisture.

Ofloxacin-Pos may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent systemic therapy may increase risk of tendon rupture. - Topical corticosteroids: may reduce antibacterial efficacy and increase infection risk. - Non‑steroidal anti‑inflammatory eye drops: potential for reduced drug penetration.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may affect ocular surface tolerance. - Other ophthalmic antibiotics: assess for additive toxicity. - Herbal supplements containing quinine: may potentiate fluoroquinolone effects.